Rayonier (RYN) Competitors $25.96 +0.02 (+0.06%) As of 10:22 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RYN vs. PCH, BCC, PLD, STAG, WY, OHI, CUBE, HR, RHP, and SBRAShould you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Potlatch (PCH), Boise Cascade (BCC), Prologis (PLD), Stag Industrial (STAG), Weyerhaeuser (WY), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP), and Sabra Healthcare REIT (SBRA). Rayonier vs. Its Competitors Potlatch Boise Cascade Prologis Stag Industrial Weyerhaeuser Omega Healthcare Investors CubeSmart Healthcare Realty Trust Ryman Hospitality Properties Sabra Healthcare REIT Rayonier (NYSE:RYN) and Potlatch (NASDAQ:PCH) are both mid-cap construction companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations. Does the media refer more to RYN or PCH? In the previous week, Rayonier had 5 more articles in the media than Potlatch. MarketBeat recorded 9 mentions for Rayonier and 4 mentions for Potlatch. Potlatch's average media sentiment score of 1.76 beat Rayonier's score of 1.46 indicating that Potlatch is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rayonier 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Potlatch 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is RYN or PCH more profitable? Rayonier has a net margin of 68.53% compared to Potlatch's net margin of 3.94%. Rayonier's return on equity of 3.39% beat Potlatch's return on equity.Company Net Margins Return on Equity Return on Assets Rayonier68.53% 3.39% 1.91% Potlatch 3.94%2.10%1.29% Is RYN or PCH a better dividend stock? Rayonier pays an annual dividend of $1.09 per share and has a dividend yield of 4.2%. Potlatch pays an annual dividend of $1.80 per share and has a dividend yield of 4.4%. Rayonier pays out 22.0% of its earnings in the form of a dividend. Potlatch pays out 339.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Do analysts prefer RYN or PCH? Rayonier presently has a consensus target price of $28.00, indicating a potential upside of 7.88%. Potlatch has a consensus target price of $49.83, indicating a potential upside of 22.05%. Given Potlatch's stronger consensus rating and higher possible upside, analysts plainly believe Potlatch is more favorable than Rayonier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rayonier 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Potlatch 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in RYN or PCH? 89.1% of Rayonier shares are held by institutional investors. Comparatively, 86.1% of Potlatch shares are held by institutional investors. 0.8% of Rayonier shares are held by insiders. Comparatively, 1.0% of Potlatch shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, RYN or PCH? Rayonier has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Potlatch has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Which has higher earnings and valuation, RYN or PCH? Rayonier has higher revenue and earnings than Potlatch. Rayonier is trading at a lower price-to-earnings ratio than Potlatch, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRayonier$1.26B3.17$359.15M$4.955.24Potlatch$1.06B2.97$21.88M$0.5377.04 SummaryRayonier beats Potlatch on 10 of the 18 factors compared between the two stocks. Get Rayonier News Delivered to You Automatically Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RYN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RYN vs. The Competition Export to ExcelMetricRayonierBLDG PRD IndustryConstruction SectorNYSE ExchangeMarket Cap$4.00B$9.78B$9.39B$21.55BDividend Yield4.18%2.21%1.86%3.49%P/E Ratio5.2429.1717.1229.98Price / Sales3.172.0097.6653.00Price / Cash18.5113.8015.3324.77Price / Book2.172.574.694.56Net Income$359.15M$297.37M$618.77M$999.02M7 Day Performance-0.70%0.65%0.38%2.13%1 Month Performance-1.54%0.79%8.83%5.37%1 Year Performance-18.12%-11.22%106.36%14.67% Rayonier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RYNRayonier4.0267 of 5 stars$25.96+0.1%$28.00+7.9%-18.0%$4.00B$1.26B5.24420Positive NewsPCHPotlatch4.467 of 5 stars$42.68-0.4%$50.00+17.2%-10.8%$3.31B$1.06B80.531,383Positive NewsBCCBoise Cascade4.9832 of 5 stars$89.00-1.1%$112.83+26.8%-38.9%$3.32B$6.72B13.077,560Positive NewsAnalyst ForecastPLDPrologis4.8948 of 5 stars$113.67+0.0%$121.83+7.2%-11.8%$105.51B$8.20B30.802,703Trending NewsAnalyst ForecastSTAGStag Industrial3.8929 of 5 stars$36.61-1.0%$38.17+4.3%-10.4%$6.83B$767.38M28.8290Positive NewsAnalyst ForecastWYWeyerhaeuser4.7292 of 5 stars$25.93-0.9%$32.88+26.8%-23.3%$18.71B$7.12B68.239,440Positive NewsOHIOmega Healthcare Investors4.29 of 5 stars$43.37+0.5%$43.38+0.0%+3.0%$12.73B$1.11B26.7750Positive NewsCUBECubeSmart3.727 of 5 stars$41.11-1.5%$46.69+13.6%-24.8%$9.37B$929.08M25.063,104Trending NewsAnalyst UpgradeHRHealthcare Realty Trust3.3083 of 5 stars$18.21+0.8%$17.20-5.5%-4.5%$6.40B$1.27B-15.83580Positive NewsAnalyst DowngradeRHPRyman Hospitality Properties4.5082 of 5 stars$100.45-0.3%$115.50+15.0%-2.2%$6.33B$2.34B23.971,929Positive NewsSBRASabra Healthcare REIT2.9033 of 5 stars$19.19+0.8%$20.71+7.9%+0.4%$4.60B$703.23M25.2540Positive News Related Companies and Tools Related Companies PCH Alternatives BCC Alternatives PLD Alternatives STAG Alternatives WY Alternatives OHI Alternatives CUBE Alternatives HR Alternatives RHP Alternatives SBRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RYN) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rayonier Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rayonier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RYN Stock Alerts